The corporate’s EBITDA elevated 22% to ₹57.2 crore, up from ₹47 crore within the yr-in the past quarter. EBITDA margin stood at 9.9% for the quarter, in contrast with 8.9% in the identical interval final yr.
Additionally Learn: IOL Chemicals will get EDQM certification for Minoxidil API
The corporate has declared an interim dividend of ₹1 per fairness share of face worth ₹2 every, representing 50%, for the monetary yr 2025-26. The corporate has fastened February 17, 2026, because the report date to find out the eligibility of shareholders entitled to obtain the interim dividend. The fee will likely be made to eligible shareholders inside 30 days of declaration.
The corporate additionally reported an distinctive merchandise of ₹11.21 crore in its monetary outcomes for the interval ended December 31, 2025. The affect arises primarily from adjustments within the wage definition following the notification of 4 Labour Codes by the Authorities of India on November 21, 2025.
Shares of IOL Chemicals and Prescribed drugs Ltd ended at ₹75.47, down by ₹5.41, or 6.69%, on the BSE.
Additionally Learn: IOL Chem Q2 Outcomes | Net profit jumps 56%, revenue up 8%, margins enhance
(Edited by : Jomy Jos Pullokaran)
First Printed: Feb 11, 2026 4:44 PM IST
Source link
#IOL #Chemicals #Outcomes #Net #profit #flat #revenue #declares #interim #dividend #CNBC #TV18
